HIGHLIGHTS
- who: Huaxin Zhu from the Department of Neurosurgery, the First Affiliated Hospital of Nanchang University, No, Yongwaizheng Street, Nanchang, Jiangxi, China have published the paper: HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas, in the Journal: (JOURNAL)
- what: This study provides multi-layered and multifaceted evidence for the importance of HMMR and establishes a HMMR-related ceRNA (HEELPAR-hsa-let-7i-5p-RRM2) overexpressed network related to the prognosis of gliomas. The authors comprehensively evaluated the predictive value of HMMR and constructed a HMMR related ceRNA network in patients with gliomas . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.